Publications by authors named "Andrew Burrow"

Claim this Profile
P
Profound hypotonia in an infant with δ-aminolevulinic acid dehydratase deficient porphyria.
Alexis N Roach, Hannah Barkley, Carissa Rodriquez, T Andrew Burrow, Karl E Anderson

Eur J Hum Genet· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Profound hypotonia in an infant with δ-aminolevulinic acid dehydratase deficient porphyria.
Alexis N Roach, Hannah Barkley, Carissa Rodriquez, T Andrew Burrow, Karl E Anderson

Eur J Hum Genet· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variants in BSN, encoding the presynaptic protein Bassoon, result in a distinct neurodevelopmental disorder with a broad phenotypic range.
Stacy G Guzman, Sarah M Ruggiero, Shiva Ganesan, Colin A Ellis, Alicia G Harrison, T Andrew Burrow

Am J Hum Genet· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variants in , encoding the presynaptic protein Bassoon, result in a novel neurodevelopmental disorder with a broad phenotypic range.
Stacy G Guzman, Sarah M Ruggiero, Shiva Ganesan, Colin A Ellis, Alicia G Harrison, T Andrew Burrow

medRxiv· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bradycardia and Acidosis in a Term Newborn.
Carson Savrick, Megha Sharma, Andrew Burrow, Jared Beavers

Neoreviews· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: A clinical practice resource.
Rebecca L Koch, Claudia Soler-Alfonso, Bridget T Kiely, Akihiro Asai, Ariana L Smith, T Andrew Burrow

Mol Genet Metab· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical insights from Wolman disease: Evaluating infantile hepatosplenomegaly.
William B Hannah, Katherine Ryan, Surekha Pendyal, T Andrew Burrow, Susan E Harley

Am J Med Genet A· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here?
Neal J Weinreb, Ozlem Goker-Alpan, Priya S Kishnani, Nicola Longo, T Andrew Burrow

Mol Genet Metab· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating psychosocial stressors in families of children with inborn errors of metabolism.
Nathan Grant, T Andrew Burrow

Mol Genet Metab Rep· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children's Hospital.
Pritmohinder S Gill, Feliciano B Yu, Patricia A Porter-Gill, Bobby L Boyanton, Judy C Allen, Andrew Burrow

J Pers Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gaucher disease and SARS-CoV-2 infection: Emerging management challenges.
Pramod Mistry, Manisha Balwani, Deborah Barbouth, T Andrew Burrow, Edward I Ginns

Mol Genet Metab· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addendum to Letter to the Editor: Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1.
Pramod K Mistry, Manisha Balwani, Hagit N Baris, Hadhami Ben Turkia, T Andrew Burrow

Blood Cells Mol Dis· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CNTNAP1-Related Congenital Hypomyelinating Neuropathy.
Harry Lesmana, Marissa Vawter Lee, Seyed Ali Hosseini, T Andrew Burrow, Barbara Hallinan

Pediatr Neurol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1.
Pramod K Mistry, Manisha Balwani, Hagit N Baris, Hadhami Ben Turkia, T Andrew Burrow

Blood Cells Mol Dis· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Squalene Synthase Deficiency: Clinical, Biochemical, and Molecular Characterization of a Defect in Cholesterol Biosynthesis.
David Coman, Lisenka E L M Vissers, Lisa G Riley, Michael P Kwint, Roxanna Hauck, T Andrew Burrow

Am J Hum Genet· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlating liver stiffness with disease severity scoring system (DS3) values in Gaucher disease type 1 (GD1) patients.
Suraj D Serai, Anjani P Naidu, T Andrew Burrow, Carlos E Prada, Stavra Xanthakos

Mol Genet Metab· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Widespread Vasculopathy in a Patient with Morquio A Syndrome.
Adam W Powell, Michael D Taylor, T Andrew Burrow, Robert J Hopkin, Carlos E Prada

Tex Heart Inst J· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Home infusion of intravenous velaglucerase alfa: Experience from pooled clinical studies in 104 patients with type 1 Gaucher disease.
Deborah Elstein, T Andrew Burrow, Joel Charrow, Pilar Giraldo, Atul Mehta

Mol Genet Metab· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stability is maintained in adults with Gaucher disease type 1 switched from velaglucerase alfa to eliglustat or imiglucerase: A sub-analysis of the eliglustat ENCORE trial.
Rebecca Pleat, Timothy M Cox, T Andrew Burrow, Pilar Giraldo, Ozlem Goker-Alpan

Mol Genet Metab Rep· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency.
Barbara K Burton, Manisha Balwani, François Feillet, Ivo Barić, T Andrew Burrow

N Engl J Med· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatic HRAS p.G12S mutation causes woolly hair and epidermal nevi.
Jonathan L Levinsohn, Joyce Teng, Brittany G Craiglow, Erin C Loring, T Andrew Burrow

J Invest Dermatol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent pancreatitis in ornithine transcarbamylase deficiency.
Carlos E Prada, Ajay Kaul, Robert J Hopkin, Kimberley I Page, Jaimie D Nathan, T Andrew Burrow

Mol Genet Metab· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac disease in methylmalonic acidemia.
Carlos E Prada, Fatma Al Jasmi, Edwin P Kirk, Maxwell Hopp, Owen Jones, T Andrew Burrow

J Pediatr· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute progression of neuromuscular findings in infantile Pompe disease.
T Andrew Burrow, Laurie A Bailey, Douglas G Kinnett, Robert J Hopkin

Pediatr Neurol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of congenital anomalies in individuals with choanal atresia.
T Andrew Burrow, Howard M Saal, Alessandro de Alarcon, Lisa J Martin, Robin T Cotton

Arch Otolaryngol Head Neck Surg· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis